FOLLOW US

Other Endocrine Disorders Research Updates

For Medical Professionals

In the first study of its kind, researchers found that all 27 consecutive professional voice users (including professional operatic performers) who underwent neural monitored thyroid surgery were able to return to performance, researchers reported in a recent issue of Thyroid.
Exposure to urinary metabolites of the phthalate compound di-isononyl phthalate (DINP), which is increasingly used in the manufacturing of consumer products, was linked to an increased risk of high diabetes in adolescents enrolled in a cross-sectional analysis reported in the Journal of Clinical Endocrinology and Metabolism.
The National Cancer Institute (NCI)-supported precision medicine trial known as NCI-MATCH (Molecular Analysis for Therapy Choice) will begin enrollment in July 2015. The goal of the trial is to determine whether select cancer treatments are effective against specific molecular abnormalities, regardless of tumor type. Learn more about the trial and how patients can enroll.
Merrimack Pharmaceuticals, Inc., has submitted a New Drug Application (NDA) for MM-398 (irinotecan liposome injection) in the treatment of patients with metastatic pancreatic cancer who were previously treated with gemcitabine-based therapy. Merrimack has requested a priority review of the NDA.
Women with high levels of endocrine-disrupting chemicals experienced menopause 2 to 4 years earlier than women with lower levels of these chemicals, according to a cross-sectional study using data from using the National Health and Nutrition Examination Survey (NHANES). The findings were published in PLoS ONE.
Patients who have Cushing’s disease and receive mifepristone must undergo surveillance for evidence of tumor progression.
Researchers identified a variety of patient and tumor-specific characteristics that predict the postoperative growth rate of pituitary adenomas, according to a retrospective review published online ahead of print in the Journal of Clinical Endocrinology and Metabolism.
Patient information for AndroGel often warns of the risk of priapism: a study published looks at how often this occurs and how high the risk is.
Growth hormone deficiency may result in an increased risk of developing type 2 diabetes mellitus.
A study conducted by researchers in Germany suggests that low testosterone levels in men may contribute to their heightened risk of cardiovascular morbidity and mortality.
The amount of time that lapses between the onset of acromegaly symptoms and the point when patients are accurately diagnosed with the condition may impact their psychosocial well-being, according to a new study.
A study explored the extent of cardiometabolic risk factors experienced by children and adolescents with Turner Syndrome.
What are the effects of surgery for hyperparathyroidism on patients’ bone mineral density (BMD)? Researchers tackled this question.
Researchers examined the effects of weight on the reproductive and metabolic features of polycystic ovary syndrome.
Researchers set out to explore the relationship between low testosterone, quality of life, and psychological health.
Are there differences in the clinical presentations of obese and non-obese adolescents with polycystic ovary syndrome?
Adolescent males with congenital adrenal hyperplasia should be tested for testicular adrenal rest tumors every 1 to 2 years.
What effects do sleep apnea and treatment for the condition have on insulin resistance in patients with acromegaly? Read the latest updates on this topic.
A recent study set out to explore hair loss following acromegaly surgery. Read more about this study in Clinical Endocrinology.
close X
SHOW MAIN MENU
SHOW SUB MENU